Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein.

Source:http://linkedlifedata.com/resource/pubmed/id/9670855

J. Neuroimmunol. 1998 Jul 1 87 1-2 136-46

Download in:

View as

Triples

General Info

PMID
9670855